| THE MEANING OF MYRIAD
Patent Law Conference |
| | Friday, September 12, 2014 9:00 a.m.–5:00 p.m. UC Irvine School of Law (map) | |
| | In 2013, the United States Supreme Court rendered its decision on gene patenting in Association of Molecular Pathology v. Myriad Genetics. The reasoning of the Myriad decision itself remains anything but clear. This conference will explore the evolving meaning of the Myriad decision for science, for industry, and for the patent system.
Keynote Speaker
Hon. Andrew Guilford, USDC Cent. Dist. Cal
Confirmed Speakers
Dan Burk, University of California, Irvine
Mark Janis, University of Indiana, Bloomington
Anna Laakman, Lewis & Clark University
Jessica Lai, University of Lucerne
Peter Lee, University of California, Davis
Mark Lemley, Stanford University
Lisa Larrimore Ouellette, Stanford University
Amelia Rinehart, University of Utah
Brad Sherman, Griffith University
| |
| | |
| |
|